April 3, 2026
Science just ratio’d your peptides
Show HN: An evidence-rated encyclopedia of peptides
Biohackers vs Buzzkill: New peptide site ranks hype, exposes ‘miracle’ injections
TLDR: A new site ranks trendy peptide injections by real human evidence, quietly revealing that most hyped “miracle” compounds have almost no solid data behind them. Commenters are split between raging biohackers defending their stacks and grateful skeptics celebrating it as Yelp-for-snake-oil, making it a must-read for anyone tempted by peptide hype.
A new “evidence-rated encyclopedia of peptides” just dropped, and the internet is treating it like Rotten Tomatoes for miracle shots. The site lists all those trendy injection compounds you see on biohacking forums and influencer podcasts, then calmly shows how many real human trials exist… which for most is basically crickets. One top commenter summed up the mood: “My $400-a-month peptide stack just got review-bombed by science.”
On one side, biohackers and gym diehards are furious, accusing the site of being a “fun police database” that will scare newbies away from “the good stuff.” Others are relieved, calling it “the first adult in the peptide room,” especially when they see that some of the most hyped compounds have zero proper human tests. Cue the meme flood: comments comparing peptide influencers to essential oil sellers, people posting “RIP BPC-157” gravestones, and one user dubbing it “Yelp for sketchy injections.”
The legal disclaimers and warnings about shady suppliers sparked more drama. Clinic fans insist their “research peptides” are safer than fast food, while skeptics clap back with stats about fake studies and paper mills. The only thing everyone agrees on? Semaglutide-style drugs, the weight-loss blockbusters, actually earned their hype. Everything else just got put on evidence watch.
Key Points
- •The site catalogs 77 peptide compounds discussed in biohacking, anti-aging, and sports medicine, rating them by evidence tier, trial count, legal status, and pharmacokinetics without making recommendations.
- •It includes 30 FDA-approved peptide drugs only as comparators relevant to these conversations, while excluding many well-established therapies like insulin, calcitonin, and enfuvirtide.
- •The database tracks 2,632 unique clinical trials from ClinicalTrials.gov and highlights that many peptides marketed online lack controlled human studies despite significant social media hype.
- •The article explains pharmacokinetic challenges of peptides—rapid degradation in stomach acid and short bloodstream half-lives—and notes that approved drugs like semaglutide required molecular engineering to extend half-life.
- •It stresses that most research peptides lack FDA approval, animal data often fails to translate to humans, scientific literature can be distorted by paper mills, and using unregulated peptides carries health and legal risks; the site is for educational purposes only, not medical advice.